Workflow
槟杰科达(01665) - 2023 Q1 - 季度业绩
PENTAMASTERPENTAMASTER(HK:01665)2023-05-11 09:02

Financial Performance - The company's revenue for Q1 2023 was RM 165.3 million, an increase of 13.2% compared to RM 145.99 million in Q1 2022[20] - Gross profit for the same period was RM 47.42 million, up from RM 44.47 million, reflecting a stable gross margin[23] - The company reported a net profit attributable to shareholders of RM 34.32 million for Q1 2023, compared to RM 33.17 million in Q1 2022[22] - The group achieved a net profit of approximately 34.3 million MYR for the quarter, an increase of about 3.5% compared to the previous year[40] - Basic and diluted earnings per share for the quarter were both 1.44 sen, consistent with the previous year's performance[40] - The company’s basic earnings per share increased from 1.39 sen in Q1 2022 to 1.44 sen in Q1 2023[56] - The EBITDA for Q1 2023 reached 38.0 million MYR, an increase of approximately 5.2% from 36.1 million MYR in Q1 2022[56] - The pre-tax profit of 34.95 million MYR for Q1 2023, compared to 34.12 million MYR in Q1 2022, reflecting a slight increase[46] Cash Flow and Assets - The company's cash and cash equivalents as of March 31, 2023, were RM 302.4 million, down from RM 328.6 million as of December 31, 2022[17] - The total assets increased to RM 1,019.08 million from RM 1,001.66 million year-over-year[26] - The total equity increased to RM 772.56 million as of March 31, 2023, compared to RM 736.71 million at the end of 2022[26] - The company recorded a net cash outflow from operating activities of 8.4 million MYR for Q1 2023, compared to a cash inflow of 2.9 million MYR in Q1 2022[46] - The net cash used in investing activities was 17.85 million MYR for Q1 2023, compared to 8.40 million MYR in Q1 2022[48] - The company incurred a foreign exchange loss of 7.3 million MYR during the period, contrasting with no foreign exchange loss in Q1 2022[56] - The company faced a net foreign exchange loss of approximately 1.6 million MYR during the quarter, primarily due to foreign exchange losses recorded under administrative expenses[38] Operational Highlights - The company has a strong order backlog entering 2023, with expectations to complete and deliver most orders within the year, particularly in the automotive and medical equipment sectors[7] - The semiconductor and consumer and industrial products markets are showing moderate growth, with revenue contributions expected to remain stable compared to the previous year[7] - The automotive segment generated 90.1 million MYR, accounting for 54.5% of total revenue, up from 52.4 million MYR (35.9%) in the previous year[37] - The medical instruments segment saw revenue increase to 19.1 million MYR, representing 11.6% of total revenue, compared to 11.1 million MYR (7.6%) in the previous year[37] - The FAS segment experienced a remarkable revenue growth of 82.7%, reaching 58.3 million MYR compared to 31.9 million MYR in the previous year, contributing 35.4% to the overall revenue[36] - The automotive sector contributed 79.1% to the revenue in Q1 2023, up from 45.2% in Q1 2022, reflecting a growth of 71.8%[52] Expenses and Costs - Administrative expenses rose to RM 19.36 million in Q1 2023 from RM 10.58 million in Q1 2022, primarily due to increased operational costs[14] - The gross profit margin for Q1 2023 was approximately 28.7%, down from 30.5% in Q1 2022, primarily due to significant adjustments in direct and indirect labor costs[54] - Other income rose to 8.0 million MYR from 3.8 million MYR year-over-year, driven by increased interest income and foreign exchange gains[38] Strategic Initiatives - The company plans to continue its growth strategy focusing on product diversification, segment diversification, and geographical expansion, including establishing a wholly-owned subsidiary in Germany[70] - The company continues to invest in factory automation solutions, enhancing its capabilities in integrated automation manufacturing solutions[5] - The company incurred research and development costs of 1.6 million MYR for a single-use medical device through its wholly-owned subsidiary Pentamaster MediQ[76] Market Trends - The semiconductor segment's contribution to the ATE sub-market decreased to 13.8% from 16.1% year-over-year, reflecting the cyclical nature of demand amid global semiconductor downturns[35] - The contribution from the optoelectronics segment significantly declined to 6.6% from 29.5% year-over-year, attributed to the ongoing downturn in the global smartphone market[35]